Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Assisted reproductive technologies: a hierarchy of risks for conception, pregnancy outcomes and treatment decisions
Author: Davies, M.
Rumbold, A.
Moore, V.
Citation: Journal of Developmental Origins of Health and Disease, 2017; 8(4):443-447
Publisher: Cambridge University Press
Issue Date: 2017
ISSN: 2040-1744
Statement of
M. J. Davies, A. R. Rumbold and V. M. Moore
Abstract: The use of assisted reproductive technologies (ART) for the treatment of infertility has grown exponentially over the last 20 years, and now accounts for 4% of all births in Australia, and over 1 m births annually around the globe. There is consistent reporting of increased risk of adverse perinatal outcomes and birth defects following infertility treatment. However, change in practice has been stymied by critical knowledge gaps with regards to (a) the relative contribution of patient and treatment factors to adverse outcomes, (b) the independent contribution of specific contemporary treatments and treatment combinations to outcomes, (c) the impact of innovations in laboratory and clinical practice on treatment success and observed risk and (d) changes over time in patient characteristics. Here we summarize key findings from the South Australian Birth Cohort, which is a whole-of-population cohort of over 300,000 births from 1986 to 2002. Relative to spontaneous conceptions, singletons from assisted conception were more likely to be stillborn [odds ratio (OR)=1.82; 95% confidence interval (CI) 1.34-2.48], while survivors as a group were comprehensively disadvantaged at birth, including lower birth weight (OR=2109 g; 95% CI 2129-289), very low birth weight (OR=2.74; 95% CI 2.19-3.43), very preterm birth (OR=2.30; 95% CI 1.82-2.90) and neonatal death (OR=2.04; 95% CI 1.27-3.26). Major birth defects, including cardiac, urogenital and musculoskeletal defects are doubled after fresh ICSI cycles, which is a particular concern as ICSI now accounts for 70% of all treatment cycles globally. Future study is needed to provide contemporary, precise evidence to inform patient and clinic decision making, and generate knowledge for future innovation in ART laboratory methods and clinical practice, thereby optimizing treatment and health outcomes while reducing adverse events.
Keywords: Developmental stage; fetus/fetus; human, pregnancy
Description: Themed Issue: Assisted Reproductive Treatments (ART) and DOHAD. Corrected by: Erratum: Assisted reproductive technologies: A hierarchy of risks for conception, pregnancy outcomes, and treatment decisions (Journal of Developmental Origins of Health and Disease DOI: 10.1017/S2040174417000526). In Journal of Developmental Origins of Health and Disease 9(2):241-246. Unfortunately the above mentioned article was published without the author’s full corrections implemented. The fully corrected version is contained in this erratum. The Publishers apologise for the error.
Rights: © Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2017
RMID: 0030073239
DOI: 10.1017/S2040174417000526
Grant ID:
Appears in Collections:Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.